Ó Springer International Publishing Switzerland / the STAR / /
Continent
Asia / /
Country
New Zealand / United States / Spain / /
Currency
pence / / /
Event
FDA Phase / Product Recall / Product Issues / /
Facility
University of Texas / University of San Diego / /
IndustryTerm
treatment of adult patients with major depressive disorder / glutamate systems / neurotransmitter systems / /
MedicalCondition
drug hypersensitivity / major depressive disorder / neurological disorders / Nausea / endstage renal disease / Major Depressive Disorder Karly P. Garnock / anxiety/ depression / benign prostatic hyperplasia / hypersensitivity / clinically significant unstable illness / back pain / mental disorders / social anxiety disorder / concurrent disorders / hypertension / cancer / disease / certain past psychiatric disorders / DFFS Depression / chronic liver disease / diabetes / sexual dysfunction / osteoarthritis / anxiety disorder / cognitive dysfunction / myocardial infarction / severe depression / related disorders / depression / /
MedicalTreatment
self-care / pharmacotherapy / /
MusicGroup
Nausea / /
NaturalFeature
Mairangi Bay / /
Organization
University of Texas / Houston / University of San Diego / Department of Psychiatry and Behavioral Sciences / European Union / Department of Neurochemistry and Neuropharmacology / /
Person
Karly P. Garnock-Jones Published / Depressive Disorder / Depressive Disorder Karly / /
CNS Drugs[removed]:855–874 DOI[removed]s40263[removed]x ADIS DRUG EVALUATION Vortioxetine: A Review of Its Use in Major Depressive Disorder